Safety study of VVZ-2471 in healthy volunteers with high impulsivity
This Phase 1 study tests how safe and well-tolerated a new experimental drug called VVZ-2471 is in healthy adults. The drug targets brain pathways involved in impulse control, and researchers want to understand its effects on people who naturally tend to act without thinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old and in generally good overall health
- Show high impulsivity on a computer test during screening (score ratio above 0.25)
- Have normal heart function, blood pressure, and lab values within safe ranges
- Not have a history of psychosis, bipolar disorder, or current psychiatric conditions like depression or anxiety
- Not be taking medications that interact with the study drug, including certain antibiotics, antifungals, antidepressants, or anti-anxiety drugs
- If female: be post-menopausal or surgically sterile; if male: agree to use contraception for 90 days after the last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This study tests a new oral investigational drug in healthy adults to see how safe it is and how the body handles it. It is an early-phase trial that helps determine the right dose and check for side effects.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This study tests a new medicine called VV261 in healthy volunteers. It looks at whether the medicine is safe and how the body handles it. You may be able to join if you are a healthy adult aged 18-45 and meet certain health requirements.
Hear when a new Healthy Controls trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.